• 1988 – MD (cum laude) in Medicine and Surgery, University of Pisa
• 1992 – Specialization in Rheumatology (cum laude), University of Pisa
• 1997 – PhD in Experimental Rheumatology, University of Siena

Since 2001, Dr. Maurizio Mazzantini has held the position of Senior Consultant (Level I Medical Director) at the Pisa University Hospital (Azienda Ospedaliero-Universitaria di Pisa), where he holds a highly specialized appointment in the medical treatment of fragility vertebral fractures.

He works within the University Rheumatology Unit, Department of Medical and Surgical Specialties, carrying out clinical, outpatient, and high-complexity service coordination activities.

He is Head of the Rheumatology Inpatient Ward and provides specialist outpatient care in several areas of rheumatology, with particular focus on skeletal disorders, arthritis, and chronic diseases with a high impact on patients’ quality of life.

In particular:

• General Rheumatology outpatient activity

• Arthritis Outpatient Clinic

• Fibromyalgia Outpatient Clinic

Dr. Mazzantini coordinates and directs several high-volume specialist services, also recognized at international level:

• Head of the Bone Densitometry Service
  (4,807 examinations performed in 2025)

• Head of the Osteoporosis and Skeletal Diseases Outpatient Clinic
  (1,438 visits in 2025)

• Co-Head of the Multidisciplinary Outpatient Clinic “Diagnosis, Treatment and Rehabilitation of Vertebral Fractures”
  (501 visits in 2025)
  Service accredited as a Fracture Liaison Service and recognized by the International Osteoporosis Foundation since 2015

• Head of the Osteoporosis Clinic for Oncology Patients
  (809 visits in 2025)

• Head of the Rare Bone and Connective Tissue Diseases Clinic
  (195 visits in 2025)

Since 2026, he has been practicing at Casa di Cura San Rossore.

His main areas of clinical and research activity include primary and secondary osteoporosis, metabolic bone diseases (including Paget’s disease, hypophosphatasia, and osteogenesis imperfecta), rare causes of skeletal fragility, and osteosclerotic diseases.

He also focuses on skeletal effects of glucocorticoids and other medications, vertebral fractures, and integrated treatment and rehabilitation pathways, including vertebroplasty and kyphoplasty.

His scientific activity includes 43 publications in international peer-reviewed journals and continuous involvement in the main national scientific societies in the field, including leadership roles. He is regularly invited as a speaker and moderator at courses and conferences dedicated to bone metabolism.

Membership in Scientific Societies

Italian Society of Rheumatology (SIR)
Member from 1992 to 2013 and again since 2022

Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS)
Member since 1992
Regional Coordinator for Tuscany (2018–2021)
Member of the Communication and Member Services Committee (since 2021)
Member of the Executive Board (since 2025)

Italian Bone Interdisciplinary Specialist Group (GIBIS)
Member
Regional Coordinator (2020–2023)
Member of the Executive Board (since 2023)

Italian Group for the Study of Bone Metabolism (GISMO)
Member

Italian Osteoporosis Federation (FEDIOS)
Board Member (since 2020)

Hypophosphatasia Patients Association (API)
Board Member (since 2020)

Rheumatologist with over twenty years of experience, he specializes in the diagnosis and treatment of skeletal and bone metabolism disorders, with particular focus on osteoporosis and fragility vertebral fractures.

He carries out both outpatient and inpatient clinical activity and coordinates highly complex specialist services. He has extensive expertise in the management of metabolic and rare bone diseases, including genetic forms and conditions secondary to pharmacological or oncological treatments.

He works within multidisciplinary care pathways for the treatment and rehabilitation of patients with vertebral fractures, including procedures such as vertebroplasty and kyphoplasty. Alongside clinical practice, he maintains an intense scientific research activity, with numerous international publications and continuous participation in the leading scientific societies in the field.